Cargando…

Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN

In their role as pattern-recognition receptors on cells of the innate immune system, myeloid C-type lectin receptors (CLRs) assume important biological functions related to immunity, homeostasis, and cancer. As such, this family of receptors represents an appealing target for therapeutic interventio...

Descripción completa

Detalles Bibliográficos
Autor principal: Cramer, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: RSC 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672822/
https://www.ncbi.nlm.nih.gov/pubmed/35024612
http://dx.doi.org/10.1039/d1md00238d
_version_ 1784615425396441088
author Cramer, Jonathan
author_facet Cramer, Jonathan
author_sort Cramer, Jonathan
collection PubMed
description In their role as pattern-recognition receptors on cells of the innate immune system, myeloid C-type lectin receptors (CLRs) assume important biological functions related to immunity, homeostasis, and cancer. As such, this family of receptors represents an appealing target for therapeutic interventions for modulating the outcome of many pathological processes, in particular related to infectious diseases. This review summarizes the current state of research into glycomimetic or drug-like small molecule ligands for the CLRs Mincle, Langerin, and DC-SIGN, which have potential therapeutic applications in vaccine research and anti-infective therapy.
format Online
Article
Text
id pubmed-8672822
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher RSC
record_format MEDLINE/PubMed
spelling pubmed-86728222022-01-11 Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN Cramer, Jonathan RSC Med Chem Chemistry In their role as pattern-recognition receptors on cells of the innate immune system, myeloid C-type lectin receptors (CLRs) assume important biological functions related to immunity, homeostasis, and cancer. As such, this family of receptors represents an appealing target for therapeutic interventions for modulating the outcome of many pathological processes, in particular related to infectious diseases. This review summarizes the current state of research into glycomimetic or drug-like small molecule ligands for the CLRs Mincle, Langerin, and DC-SIGN, which have potential therapeutic applications in vaccine research and anti-infective therapy. RSC 2021-09-16 /pmc/articles/PMC8672822/ /pubmed/35024612 http://dx.doi.org/10.1039/d1md00238d Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Cramer, Jonathan
Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN
title Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN
title_full Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN
title_fullStr Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN
title_full_unstemmed Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN
title_short Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN
title_sort medicinal chemistry of the myeloid c-type lectin receptors mincle, langerin, and dc-sign
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672822/
https://www.ncbi.nlm.nih.gov/pubmed/35024612
http://dx.doi.org/10.1039/d1md00238d
work_keys_str_mv AT cramerjonathan medicinalchemistryofthemyeloidctypelectinreceptorsminclelangerinanddcsign